Bone Cutting Surgical Tool Market Overview
According to a new report published by Introspective Market Research, titled, “Bone Cutting Surgical Tool Market by Product Type, Technology Type, Application: Global Opportunity Analysis and Industry Forecast, 2024–2032,”
The Bone Cutting Surgical Tool Market Size Was Valued at USD 12.55 Billion in 2023, and is Projected to Reach USD 23.47 Billion by 2032, Growing at a CAGR of 7.2% From 2024-2032.
The market for clinical devices and instruments designed for cutting bones during surgeries is known as the Bone Cutting Surgical Tool Market. These instruments are commonly used in medical procedures, such as joint replacements, fracture fixations, and spinal surgeries. The market encompasses a variety of surgical devices for cutting bones, such as saws, drills, osteotomes, and burrs, used to precisely cut and shape bones based on surgical needs.
Typically, these tools consist of a pointed blade or a serrated edge attached to a handle. Using materials such as treated steel or tungsten carbide ensures the durability and longevity of the edges of these instruments. Various precise tools are available for cutting bones, such as oscillating saws, reciprocating saws, and precision bone cutters. Power and compressed air are both viable options for powering them to achieve precise and efficient cutting.
The increasing dominance of Chronic Diseases driving the orthopedic surgical device market. Chronic conditions such as osteoarthritis, osteoporosis, and bone cancers often necessitate careful interventions to restore mobility, relieve pain, or address complications. These situations may cause bone deformities, fractures, or the need for bone removal. With a growing global population aging and the increasing prevalence of chronic conditions, there is a rising demand for surgical instruments used for cutting bones. Experts rely on these tools for precise bone-cutting and reshaping procedures in muscle surgeries, joint replacements, cancer removals, and trauma situations.
The increasing popularity of minimally invasive procedures offers important opportunities in the healthcare industry. A minimally invasive surgical procedure, also known as laparoscopic or keyhole surgery, involves performing procedures through tiny incisions rather than traditional open surgery. This method provides multiple benefits for patients, healthcare providers, and the healthcare system as a whole, creating a positive impact on the market for devices. Minimally invasive techniques often yield superior outcomes in terms of noise improvement compared to traditional open surgery. Typically, these methods result in less pain, reduced blood loss, decreased risk of infection, and quicker recovery periods.
Global Bone Cutting Surgical Tool Market, Segmentation
The Bone Cutting Surgical Tool market is segmented on the basis of Product Type, Technology Type, Application, and region.
Product Type:
The type segment is further classified into Systems and disposables. Among these, the Systems sub-segment accounted for the highest market share in 2023. The System segment's strong presence in the bone-cutting precise tool market indicates a movement toward more advanced and integrated innovations in orthopedic surgeries. Frameworks refer to integrated platforms that combine multiple specialized tools, instruments, and technologies into a cohesive system. These frameworks often combine robotics, navigation systems, and advanced imaging techniques to improve surgical precision, accuracy, and efficiency.
Technology Type:
The application segment is further classified into Drills, Burs, Lasers, Piezo Tomes, and Others. Among these, the Drills sub-segment is anticipated to show the fastest growth by 2032. The significance of the Drills category within the Technology Type section of the bone-cutting surgical tool market underscores its importance and widespread utilization in orthopedic surgeries. Drills are versatile medical instruments used in a range of orthopedic procedures like joint replacements, fracture fixation, spinal surgeries, and orthopedic trauma surgeries. Orthopedic surgeons consider them crucial instruments, as they can make precise holes in bone tissue.
Market Segmentation
By Product Type
- Systems
- Disposables
By Technology Type
- Drills
- Burs
- Lasers
- Piezo tomes,
- Others
By Application
- Partial Knee Replacement
- Total Knee Replacement
- MIS Fusion
- Endochondral ossification
- Others
Region:
The Bone Cutting Surgical Tool market in North America is projected to show the fastest growth by 2032. The market for surgical tools used for cutting bones can be segmented geographically, with North America expected to be at the forefront of the market in the near future. In North America, there exists a well-developed healthcare system that includes hospitals, surgical centers, and specialized clinics. The district's market for precise bone-cutting tools is growing due to state-of-the-art equipment and highly trained medical staff in the advanced healthcare system. In the healthcare sector, North America is at the forefront of technological advancements, with a focus on enhancing precision and accuracy in surgical procedures.
Some of the leading Bone Cutting Surgical Tool market players are
- Conmed Corporation (US)
- Microaire Surgical Instruments LLC (US)
- Depuy Synthes Companies (US)
- Arthrex Inc. (US)
- Olympus Corporation (Japan)
- Karl Storz Se & Co. Kg (Germany)
- B. Braun Melsungen AG (Germany)
- Richard Wolf Gmbh (Germany)
- Aesculap Inc. (Germany)
- Tekno-Medical Optik-Chirurgie Gmbh (Germany), and Other Active Players.
Key Industry Developments
- In April 2024, Stryker, a global leader in medical technologies, announced that it had completed the acquisition of mfPHD, a leader in modular stainless-steel wall systems for hospitals and ambulatory surgery centers. The acquisition allowed for innovative product development opportunities to build out an ecosystem of embedded technologies delivering data and analytics for an intelligent operating room, minimizing downtime and costly renovations.
- In March 2024, Medtronic plc announced that the Evolut™ FX+ transcatheter aortic valve replacement (TAVR) system has been approved by the United States Food and Drug Administration (FDA) for treating symptomatic severe aortic stenosis. The newest Evolut FX+ TAVR system retains the valve benefits from the original Evolut TAVR platform and aims to make coronary access easier.
Key Findings of the Study / Key Industry Developments.
- Essential in joint replacements, fracture fixations, and spinal surgeries for precise bone cutting and shaping.
- Materials like treated steel or tungsten carbide ensure durability, with tools including saws, drills, and burrs.
- Demand driven by chronic diseases like osteoarthritis and bone cancers, necessitating interventions.
